Please wait a minute...
文章检索
预防医学  2025, Vol. 37 Issue (7): 677-681    DOI: 10.19485/j.cnki.issn2096-5087.2025.07.007
  论著 本期目录 | 过刊浏览 | 高级检索 |
2014—2023年温州市胃癌疾病负担趋势分析
吴沥豪, 叶振淼, 林德威, 陈海东
温州市疾病预防控制中心(温州市卫生监督所),浙江 温州 325000
Trend in disease burden of gastric cancer in Wenzhou City from 2014 to 2023
WU Lihao, YE Zhenmiao, LIN Dewei, CHEN Haidong
Wenzhou Center for Disease Control and Prevention (Wenzhou Institute of Public Health Supervision), Wenzhou, Zhejiang 325000, China
全文: PDF(818 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 分析2014—2023年浙江省温州市胃癌疾病负担变化趋势,为完善胃癌防治措施提供依据。方法 通过温州市慢性病监测管理信息系统收集2014—2023年温州市户籍居民胃癌发病和死亡资料,计算粗发病率和粗死亡率;参考世界卫生组织疾病负担方法计算早死损失寿命年(YLL)、伤残损失寿命年(YLD)和伤残调整寿命年(DALY),评价胃癌疾病负担。采用平均年度变化百分比(AAPC)分析2014—2023年温州市胃癌YLL率、YLD率和DALY率的变化趋势。结果 2014—2023年温州市累计报告胃癌发病28 122例,死亡17 080例;粗发病率和粗死亡率分别为34.13/10万和20.73/10万。2014—2023年温州市胃癌YLL、YLD和DALY分别为181 816.78、53 198.41和235 015.19人年,YLL率、YLD率和DALY率分别为2.21、0.64和2.85人年/千人;YLL率、DALY率呈下降趋势(AAPC=-4.608%和-2.552%,均P<0.05),YLD率呈上升趋势(AAPC=4.657%,P<0.05)。男性胃癌DALY率为3.82人年/千人,女性为1.83人年/千人,呈下降趋势(AAPC=-2.924%和-1.647%,均P<0.05)。15~<45岁组胃癌DALY率较低,45岁上升,≥70岁组达到高峰,为14.09人年/千人;15~<45岁、45~<70岁和≥70岁组胃癌DALY率呈下降趋势(AAPC=-3.626%、-5.450%、-4.404%,均P<0.05)。结论 2014—2023年温州市胃癌DALY率总体呈下降趋势,主要由早死损伤引起;男性和老年人胃癌疾病负担较重,建议采取针对性的防控措施降低居民胃癌疾病负担。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
吴沥豪
叶振淼
林德威
陈海东
关键词 胃癌早死损失寿命年伤残损失寿命年伤残调整寿命年    
AbstractObjective To investigate the trend of gastric cancer disease burden in Wenzhou City, Zhijiang Province from 2014 to 2023, so as to providing evidence for prevention and control strategies. Methods Data on incidence and mortality of gastric cancer among household registered residents in Wenzhou City from 2014 to 2023 were collected through the Wenzhou Chronic Disease Monitoring and Management Information System, and the crude incidence and crude mortality were calculated. The disease burden of gastric cancer was evaluated by calculating years of life lost (YLL), years lived with disability (YLD), and disability-adjusted life years (DALY) using the World Health Organization's disease burden methodology. Trends in YLL rate, YLD rate and DALY rate of gastric cancer from 2014 to 2023 were analyzed using the average annual percent change (AAPC). Results A total of 28 122 cases of gastric cancer and 17 080 deaths were reported in Wenzhou City from 2014 to 2023. The crude incidence and crude mortality were 34.13/105 and 20.73/105, respectively. The YYL, YLD and DALY caused by gastric cancer were 181 816.78, 53 198.41, and 235 015.198 person-years, and the YLL rate, YLD rate and DALY rate were 2.21, 0.64 and 2.85 person-years per 1 000 people, respectively. The YLL rate and DALY rate showed a downward trend (AAPC=-4.608% and -2.552%,both P<0.05), while the YLD rate showed an upward trend (AAPC=4.657%, P<0.05). The DALY rate of gastric cancer in men was 3.82 person-years per 1 000 people, and that in women was 1.83 person-years per 1 000 people, with a downward trend (AAPC=-2.924% and -1.647%, both P<0.05). The DALY rate of gastric cancer was relatively low in the 15 to <45 years age group, increased starting from the age of 45 years, and peaked in the ≥70 years age group, reaching 14.09 person-years per 1 000 peoples. The DALY rate of gastric cancer among residents aged 15 to <45 years, 45 to <70 years and ≥70 years showed a downward trend (AAPC=-3.626%, -5.450% and -4.404%, all P<0.05). Conclusions From 2014 to 2023, the DALY rate of gastric cancer in Wenzhou City demonstrated a sustained decline, primarily driven by a the loss of life years due to premature death. Males and older people continue had a heavier disease burden. It is recommended to implement targeted prevention and control measures to reduce the disease burden of gastric canceron among residents.
Key wordsgastric cancer    years of life lost    years lived with disability    disability-adjusted life years
收稿日期: 2025-04-14      修回日期: 2025-06-13      出版日期: 2025-07-10
中图分类号:  R735.2  
基金资助:温州市科技计划项目(Y20240846)
作者简介: 吴沥豪,硕士,医师,主要从事公共卫生工作
通信作者: 叶振淼,E-mail:195253355@qq.com   
引用本文:   
吴沥豪, 叶振淼, 林德威, 陈海东. 2014—2023年温州市胃癌疾病负担趋势分析[J]. 预防医学, 2025, 37(7): 677-681.
WU Lihao, YE Zhenmiao, LIN Dewei, CHEN Haidong. Trend in disease burden of gastric cancer in Wenzhou City from 2014 to 2023. Preventive Medicine, 2025, 37(7): 677-681.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2025.07.007      或      http://www.zjyfyxzz.com/CN/Y2025/V37/I7/677
[1] BRAY F,LAVERSANNE M,SUNG H,et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2024,74(3):229-263.
[2] 李茁钰,刘凯,张维汉,等.全球及中国胃癌的流行病学特点及趋势:2018—2022《全球癌症统计报告》解读[J].中国普外基础与临床杂志,2024,31(10):1236-1245.
LI Z Y,LIU K,ZHANG W H,et al.Epidemiologic features and trends of gastric cancer in the world and China:interpretation of the GLOBOCAN 2018-2022[J].Chin J Bases Clin Gen Surg,2024,31(10):1236-1245.(in Chinese)
[3] HE F F,WANG S M,ZHENG R S,et al.Trends of gastric cancer burdens attributable to risk factors in China from 2000 to 2050[J/OL].Lancet Reg Health West Pac,2024,44[2025-06-13].https://doi.org/10.1016/j.lanwpc.2023.101003.
[4] HAN B F,ZHENG R S,ZENG H M,et al.Cancer incidence and mortality in China,2022[J].J Natl Cancer Cent,2024,4(1):47-53.
[5] 温州市疾病预防控制中心(温州市卫生监督所).温州市2023年癌谱报告[EB/OL].[2025-06-13].https://wjw.wenzhou.gov.cn/art/2024/4/15/art_1229419335_58916863.html.
[6] 王超. 中国生物医学文献数据库中罕见疾病数据回顾性研究[D].济南:济南大学,2015.
WANG C.Retrospective study on rare disease data in Chinese biomedical literature database[D].Jinan:University of Jinan,2015.(in Chinese)
[7] 葛阳,汪俞威,宇传华.利用DisMod软件分析江干区三种癌症的疾病负担[J].中国卫生统计,2013,30(6):910-912.
GE Y,WANG Y W,YU C H.Using DisMod software to analyze the disease burden of three kinds of cancers in Jianggan District[J].Chin J Health Stat,2013,30(6):910-912.(in Chinese)
[8] KRUIJSHAAR M E,BARENDREGT J J,HOEYMANS N.The use of models in the estimation of disease epidemiology[J].Bull World Health Organ,2002,80(8):622-628.
[9] 阎月明,刘阳,江国虹,等.基于DisMod校正法对天津市2007—2015年发病监测系统中急性心肌梗死发病报告完整性判断[J].中国公共卫生,2019,35(7):861-865.
YAN Y M,LIU Y,JIANG G H,et al.Completeness of acute myocardial infarction incidence reports in Chronic Disease Incidence Surveillance System of Tianjin city,2007 to 2015:an evaluation using DisMod software[J].Chin J Public Health,2019,35(7):861-865.(in Chinese)
[10] 曾令乾. 慢性病疾病负担的计算及应用[D].合肥:中国科学技术大学,2019.
ZENG L Q.Calculation and application of chronic disease burden[D].Hefei:University of Science and Technology of China,2019.(in Chinese)
[11] YANG W J,ZHAO H P,YU Y,et al.Updates on global epidemiology,risk and prognostic factors of gastric cancer[J].World J Gastroenterol,2023,29(16):2452-2468.
[12] 赵琳,蒋龙艳,徐斌,等.南宁市五种主要恶性肿瘤发病率分析[J].预防医学,2025,37(2):135-138.
ZHAO L,JIANG L Y,XU B,et al.Incidence characteristics of five major malignant tumors in Nanning City[J].China Prev Med J,2025,37(2):135-138.(in Chinese)
[13] 郑纲,张沛绮,陈茜,等.温州市鹿城区居民慢性病相关行为危险因素现况调查[J].中国农村卫生事业管理,2018,38(11):1447-1449.
ZHENG G,ZHANG P Q,CHEN X,et al.Risk factors of chronic disease behavior among residents in Lucheng District,Wenzhou[J].Chin Rural Health Serv Adm,2018,38(11):1447-1449.(in Chinese)
[14] 杜君彦,潘杰,周晴接,等.2013—2020年浙江温州地区幽门螺杆菌耐药情况分析[J].中国全科医学,2023,26(7):825-829.
DU J Y,PAN J,ZHOU Q J,et al.The Helicobacter Pylori antibiotic resistance in Wenzhou,Zhejiang from 2013 to 2020[J].Chin Gen Pract,2023,26(7):825-829.(in Chinese)
[15] 曾玲,胥馨尹,谭大华,等.2015—2019年四川省肿瘤登记地区胃癌发病与死亡变化趋势分析[J].中国肿瘤,2024,33(7):535-541.
ZENG L,XU X Y,TAN D H,et al.Trends in incidence and mortality of gastric cancer in Sichuan cancer registration areas from 2015 to 2019[J].China Cancer,2024,33(7):535-541.(in Chinese)
[16] 浙江省民政厅. 2023年浙江省老年人口和老龄事业统计公报[EB/OL].[2025-06-13].https://mzt.zj.gov.cn/art/2024/8/20/art_1229776733_5351453.html.
[1] 叶振淼, 樊丽辉, 姜雪霞, 郑宇航, 张默涵, 罗永园, 谢轶敏, 李慧君, 金茜. 2014—2023年温州市胃癌死亡及减寿趋势分析[J]. 预防医学, 2025, 37(3): 267-271.
[2] 陈淑淑, 龚巍巍, 关云琦, 周晓燕, 潘劲, 戴品远, 王浩, 李娜, 俞敏. 1990—2019年浙江省结直肠癌疾病负担和危险因素分析[J]. 预防医学, 2024, 36(3): 203-206.
[3] 李嘉怡, 赵欣羽, 刘沁娴, 宁祖乐, 杜进林. 1990—2019年中国35岁以下人群白血病疾病负担趋势[J]. 预防医学, 2024, 36(12): 1022-1027.
[4] 曹婉婷, 胡秀兰, 韩荣荣. 2014—2023年临平区脑卒中疾病负担趋势[J]. 预防医学, 2024, 36(11): 988-991,995.
[5] 张铁威, 张艳, 刘冰, 秦康, 李标, 徐珏. 2013—2021年杭州市糖尿病死亡及疾病负担分析[J]. 预防医学, 2023, 35(9): 752-756.
[6] 王永, 包凯芳, 王思嘉, 陈洁平, 崔军, 应焱燕, 朱银潮, 李思萱, 徐典. 2011—2022年宁波市胃癌发病和死亡趋势分析[J]. 预防医学, 2023, 35(7): 557-562.
[7] 何晓庆, 罗进斌, 陈强, 魏芳. 2009—2021年金华市职业性尘肺病疾病负担分析[J]. 预防医学, 2023, 35(7): 620-624.
[8] 马昭君, 李伟伟, 董建梅, 周金意, 韩仁强, 秦绪成. 1990—2019年江苏省白血病疾病负担分析[J]. 预防医学, 2023, 35(4): 282-285,290.
[9] 周洁, 谭自明, 茹凉. 1990年与2019年中国0~14岁儿童肿瘤疾病负担分析[J]. 预防医学, 2023, 35(3): 205-209.
[10] 秦敏晔, 邱晶, 王洵之, 赵丽霞, 陆艳. 2006—2022年张家港市60岁及以上居民前列腺癌疾病负担分析[J]. 预防医学, 2023, 35(12): 1080-1083, 1088.
[11] 胡碧波, 傅克本, 顾永权. 2011—2018年余姚市恶性肿瘤发病趋势[J]. 预防医学, 2023, 35(1): 44-47,52.
[12] 张洁, 费方荣, 胡如英, 龚巍巍, 钟节鸣. 浙江省慢性病主要危险因素的归因疾病负担研究[J]. 预防医学, 2022, 34(6): 541-546,554.
[13] 杨丹丹, 姚学成, 张昕涵, 唐梦龄, 王建炳, 金明娟, 陈坤. 中国人群胃癌发病影响因素的Meta分析[J]. 预防医学, 2022, 34(6): 561-570.
[14] 林永兴, 刘足云, 李娜, 于村. 1990—2019年浙江省心血管疾病负担变化趋势[J]. 预防医学, 2022, 34(10): 1020-1025.
[15] 季巧英,刘晓红,杜冬明,杨延平,尤丹. 丽水市居民胃癌发病和死亡特征分析[J]. 预防医学, 2019, 31(11): 1108-1111.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed